Delaware Chancery Court Allows Derivative Suit Vs. Botox Directors
Directors of Allergan Inc. must face a lawsuit over $600 million in fines the company paid for misbranding its Botox treatment to smooth out wrinkles, a Delaware judge ruled, in a decision that could affect securities litigation in that state. …
